Andrew Marr to speak on EVMPD at the Appel Consulting’s Pharmacovigilance Global Summit

On 6 December 2011, Andrew Marr will be speaking at Appel Consulting’s Pharmacovigilance Global Summit on ‘The impact of EMAs announcement to make
submission of EVMPD data mandatory’.

Topics to be covered include

  • Data requirements and timlines
  • Impact assessment
  • Technology and process options for Marketing Authorisation Holders

More details and registation information can be found by following this link.